SCHEMBL983745

SCHEMBL983745

NC(=O)N1CCSCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3629899 0.84
SCHEMBL15808681 0.79 FAAH (0.39)
SCHEMBL572569 0.78 ALDH1A1 (0.45)
SCHEMBL422638 0.78
SCHEMBL20910881 0.77 AKR1C3 (0.52)
SCHEMBL337228 0.74
SCHEMBL1832720 0.74
SCHEMBL1363715 0.73
SCHEMBL302276 0.73
SCHEMBL788760 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180327396-A1 NOVEL PYRIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2018-11-15 US claimed
EP-3126359-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. Hoffmann-La Roche AG (CH) 2017-02-08 EP claimed
US-20160376262-A1 NOVEL PYRIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2016-12-29 US claimed
WO-2015150440-A1 PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2015-10-08 WO claimed
EP-1730152-B1 TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME MITSUBISHI TANABE PHARMA CORP (JP) 2012-05-02 EP claimed
JP-4759762-B2 2011-08-31 JP claimed
US-7235552-B1 Cholenic acid amides and pharmaceutical compositions thereof RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY, INC. (US) 2007-06-26 US claimed
EP-1666037-A2 Compositions for stimulating neurite growth Vertex Pharmaceuticals Incorporated (US) 2006-06-07 EP claimed
US-20050090482-A1 mixture of antibiotics, carriers and activators such as (S)-1-((3,4,5-Trimethoxyphenyl)-methyl-carbamoyl)-piperidine-2-carboxylic acid 4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)-butyl ester, used for treatment of bacterial infection in mammals VERTEX PHARMACEUTICALS INCORPORATED 2005-04-28 US claimed
EP-1129070-A4 NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS BRISTOL MYERS SQUIBB CO (US) 2005-03-02 EP claimed
EP-0831812-A2 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH Vertex Pharmaceuticals Incorporated (US) 1998-04-01 EP claimed
US-5723459-A IMMUNOSUPPRESSANTS FOR MULTIDRUG RESISTANCE VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-03-03 US claimed
US-5717092-A Compounds with improved multi-drug resistance activity VERTEX PHARMACEUTICALS INC. (US) 1998-02-10 US claimed
WO-1997036869-A1 N-(2 OXOACETYL OR SULPHONYL)-PYRROLIDINE/PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES WITH IMPROVED MULTI-DRUG RESISTANCE ACTIVITY VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-10-09 WO claimed
US-5620971-A Biologically active acylated amino acid derivatives VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-04-15 US claimed
WO-1996041609-A2 METHODS AND COMPOSITIONS FOR STIMULATING NEURITE GROWTH VERTEX PHARMACEUTICALS INCORPORATED (US) 1996-12-27 WO claimed
EP-0737204-A1 CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME CYTEL CORPORATION (US) 1996-10-16 EP claimed
EP-0662958-A1 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-07-19 EP claimed
WO-1995015973-A1 CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME CYTEL CORPORATION (US) 1995-06-15 WO claimed
WO-1994007858-A1 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS VERTEX PHARMACEUTICALS INCORPORATED (US) 1994-04-14 WO claimed